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Genome-wide association study in collies identifies a novel locus for
dermatomyositis
Rooksana E. Noorai, Leigh Anne Clark
Department of Genetics and Biochemistry, Clemson University, Clemson, South Carolina 29634-0318
Introduction

Discussion

Dermatomyositis (DM) is an autoimmune disease of dogs
characterized by an inflammatory response in the skin and
muscle tissue, typically around the face, paws, and tail.
Clinical findings consistent with DM include the development
of skin lesions such as hair loss, redness, scaling and
crusting (Figure 1). Dogs afflicted with DM often develop
disfiguring scarring and secondary skin infections. Signs of
muscle involvement in severe cases include muscle atrophy,
megaesophagus, aspiration pneumonia, and difficulty eating
or walking [1]. Naturally occurring DM in the dog is the only
animal model available for study of a clinically similar human
disease termed juvenile dermatomyositis.

In this study we utilized genome-wide SNP profiles to identify
a genomic region associated with DM. The majority of
associated SNPs, and those with the most significant pvalues, were clustered on chromosome 10. A large haplotype
spanning this region is present in all DM-affected collies.

Diagnosis of DM is made by a veterinary histopathologist
using skin punch biopsies of actively afflicted tissue. Current
treatment for DM includes the management of symptoms,
such as severe pain and secondary skin infections.
Unfortunately, there is no cure for DM and clinical signs may
reoccur. Onset of DM ranges from two months to several
years of age. A dog may have produced multiple litters before
the onset of clinical signs, making it difficult for breeders to
control disease transmission.
The two breeds with the highest prevalence of DM are collies
and Shetland sheepdogs [1 - 3]. The inheritance of DM is
suggested to be autosomal dominant [2]. Anecdotal reports
suggest that triggers for developing DM may include
vaccination, abrasion, estrus, or abandonment. In this study,
we sought to use a genome-wide association study to
identify the genetic factor(s) underlying DM in the collie
breed.

Materials & Methods
• Blood samples from DM-affected and healthy pedigreed collies were
recruited from the pet population.
• All DM-affected collies had a positive or differential diagnosis of
DM.

Figure 1. Collie and Shetland sheepdogs affected with
dermatomyositis. Skin lesions are shown on the face and feet.

Results
A total of 46 collies samples were obtained, primarily from the
United States. The age of DM affected collies ranged from 3
months to 11 years (at the time of sampling), while control
dogs were 7 to 12 years. Case/control analyses were carried
out using 26 DM-affected and 20 healthy collies (Figure 2a). A
total of 90 SNPs were significantly associated with DM (Praw
≤0.0001), 68 of which were located at the centromeric end of
chromosome 10 (Figure 2b). The most significant result
obtained was for SNP BICF2P147652, located on
chromosome 10 at position 5.15Mb (Praw = 3.03 x 10-9).
Analysis of genotypes in the chromosome 10 region revealed
a 10.5 Mb haplotype for which all DM-affected collies had at
least one copy (12 homozygous, 14 heterozygous). The
haplotype was also present in 60% of healthy collies (2
homozygous, 10 heterozygous).
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These data support an autosomal dominant mode of
inheritance, as all affected dogs carried one or two copies of
the associated haplotype. Because the haplotype was also
present among controls, the allele shows reduced
penetrance, perhaps due to an environmental trigger. While
we were unable to grade the severity of the clinical signs in
all participants, it is interesting that puppies younger at age
of onset were more often homozygous. This finding suggests
that while one copy is sufficient for disease onset, two copies
may cause a younger age of onset and/or a more severe
phenotype.
The associated haplotype harbors ~100 genes, including
several with an immune related function. To reduce the
number of candidate genes, future studies will focus on DM
in Shetland sheepdogs. These herding breeds share a recent
common ancestor and likely share a founding mutation. An
across-breed approach will allow us to use differences in
homogeneity that exist between the breeds to narrow the
haplotype. We have identified a locus on chromosome 10 that
likely harbors a genetic factor underlying DM.
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• All healthy control collies were at least 7 years old, free from any
dermatologic conditions, unrelated to a DM-affected collie, and
unrelated to all other study collies within 3 generations.
• DNA was isolated from whole blood samples using the DNeasy
blood and tissue kit (QIAGEN, Valencia, USA) and adjusted to a
concentration of 100ng/ µL.
• Illumina CanineHD Infinium BeadChips were used to profile 173,662
SNP genotypes per collie.
• GenomeStudio was used to analyze the raw data files and generate
SNP calls.
• The PLINK input Report Plug-in v2.1.1 was used to format the data.
• By convention, Praw values ≤ 0.0001 were considered significant.
• R was used to generate a Manhattan Plot from the –log10 of the Praw
value for each SNP.

Figure 2. Genome-wide association for DM using 26 affected and 20 healthy control collies. (a) Raw P values (-log10 Praw) for each SNP are
plotted by chromosome and reveal a strong association on chromosome 10 (b) The raw P values are plotted against position on
chromosome 10 and show that the significant SNPs are clustered near the centromeric end.

